A Primer on IgE-Mediated Food Allergies, With Drs. Kelly Cleary and Barbara Yawn
In this CE podcast, developed in collaboration with Food Allergy Research & Education (FARE), experts review the pathophysiological underpinnings of IgE-mediated food allergies and discuss the importance of shared decision-making and interdisciplinary approaches to optimize patient care.
|
|
Ace the Case: A 15-Year-Old Girl With a Remote History of Rash While Taking Amoxicillin
This educational activity will utilize a case study to discuss a 15-year-old girl with a remote history of a rash while taking amoxicillin.
|
|
Ace the Case: A 38-Year-Old Man With Resistant Hypertension
This educational activity will utilize a case study to discuss a 38-year-old man with resistant hypertension.
|
|
Ace the Case: A 47-Year-Old Woman With Lethargy, Confusion, and Muscle Weakness
This educational activity will utilize a case study to discuss a 47-year-old woman with lethargy, confusion, and muscle weakness.
|
|
Ace the Case: A 77-Year-Old Man With Chronic Heartburn and Persistent Abdominal Pain
This educational activity will utilize a case study to discuss a 77-year-old man who presents with a history of chronic heartburn and 3 months of persistent abdominal pain.
|
|
Advances in the Management of IgE-Mediated Food Allergies, With Drs. Kelly Cleary and Robert Wood
In this podcast, expert clinicians will discuss the efficacy and safety of traditional and emerging treatments as well as evidence-based guidance for managing patients with immunoglobulin E (IgE)-mediated food allergies.
|
|
Beyond Avoidance: IgE-Mediated Food Allergies " Therapeutic Innovations to the Rescue
In the United States, food-induced allergic reactions are the leading cause of anaphylaxis in hospital emergency departments. Among these, immunoglobulin E (IgE)-mediated food allergies are the most common, and they pose significant risks, including cardiac arrest and respiratory failure. Traditionally, treatment options for IgE-mediated food allergies have been primarily limited to food avoidan...
|
|
Extending Dosing Intervals in Retinal Disease: Patient Perspectives and Clinical Insights to Guide Your Practice
Neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) are increasingly prevalent retinal diseases that pose significant challenges in ophthalmic care. While anti-vascular endothelial growth factor (VEGF) therapies have greatly improved visual outcomes for patients with these conditions, real-world data indicate that many patients receive suboptimal treatment and mo...
|
|
GA and Advances in Imaging and Surgery: State-of-the-Art Management
The continued evolution of diagnostic, therapeutic, and surgical algorithms for the management of patients with retinal diseases offer the potential for enhancing visual, anatomical, and quality-of-life outcomes in these patients. Recognition, understanding, and application of these evidence-based advances are imperative to enhance treatment outcomes and patient satisfaction. During Part 2 of th...
|
|
Geographic Atrophy Secondary to Age-Related Macular Degeneration: Innovative Therapies for Sight Revival
Multimodal imaging is key for the early detection and monitoring of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Optical coherence tomography has recently been recommended by an international consensus to be the primary imaging method for the detection of atrophy in eyes. Once diagnosed, timely therapeutic intervention should be initiated with recently FDA-approve...
|
|
HER3 in NSCLC " Navigating New Frontiers in Targeted Therapy
In patients with non-small cell lung cancer (NSCLC), human epidermal growth factor receptor 3 (HER3) is associated with both advanced disease and resistance to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)"directed therapies. Although there are therapeutic options targeting EGFR (HER1) and HER2, the potential of HER3 as an anti-cancer target has been largely overlook...
|
|
Hypertrophic Cardiomyopathy: Unmasking Disparities and Forging a Path to Equitable Care
This comprehensive continuing education (CE) monograph delves into the complexities of HCM, an autosomal dominant genetic disorder marked by increased left ventricular hypertrophy. This condition can lead to significant health complications, such as heart failure, arrhythmias, stroke, and sudden cardiac death. Despite the impact of HCM on patient health and well-being, a gap persists in the unde...
|
|
Hypertrophic Cardiomyopathy: Unmasking Disparities and Forging a Path to Equitable Care
This comprehensive continuing education (CE) monograph delves into the complexities of HCM, an autosomal dominant genetic disorder marked by increased left ventricular hypertrophy. This condition can lead to significant health complications, such as heart failure, arrhythmias, stroke, and sudden cardiac death. Despite the impact of HCM on patient health and well-being, a gap persists in the unde...
|
|
Inherited Retinal Diseases: Navigating the Future of Diagnostics and Emerging Therapies
The differential diagnosis and workup of a suspected inherited retinal disease (IRD) can be challenging, requiring the expertise of the multidisciplinary healthcare team. Guidelines released in 2022 by the American Academy of Ophthalmology provide recommendations and clinical genetic assessments for patients with IRDs. Genetic counseling is essential to help patients understand the genetic test ...
|
|
Mastering Suboptimal Treatment Response in DME
In this Master Class case, Dr. W. Lloyd Clark discusses the management of a 75-year-old Black woman with diabetic macular edema who has a suboptimal treatment response to initial anti-vascular epithelial growth factor therapy.
|
|
Mastering Suboptimal Treatment Response in nAMD
In this Master Class case, Dr. David Eichenbaum discusses the management of a 69-year-old White man with neovascular age-related macular degeneration who receives a suboptimal treatment response to initial anti-vascular epithelial growth factor therapy.
|
|
Mastering Treatment-Naive DME
In this Master Class case, Dr. Mark R. Barakat discusses the management of a 76-year-old White man with treatment-naive diabetic macular edema.
|
|
Mastering Treatment-Naive nAMD
In this Master Class case, Dr. Priya Vakharia discusses the management of a 72-year-old White man with treatment-naive neovascular age-related macular degeneration.
|
|
Mastering Treatment-Refractory DME
In this Master Class case, Dr. Diana Do discusses the management of a 58-year-old White woman with treatment-refractory diabetic macular edema.
|
|
Mastering Treatment-Refractory nAMD
In this Master Class case, Dr. Michael Singer discusses the management of an 82-year-old Hispanic man with treatment-refractory neovascular age-related macular degeneration.
|
|
nAMD and DME: Novel Treatment Plans to Prioritize Real-World Visual Improvements
Frequent intravitreal injections of anti-vascular endothelial growth factor (VEGF) therapies can significantly improve visual and anatomical outcomes for many patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). However, the requisite high number of treatments often leads to less-than-ideal results compared to outcomes reported in major clinical tri...
|
|
nAMD, Diabetic Eye Disease, and RVO: State-of-the-Art Management
The continued evolution of diagnostic, therapeutic, and surgical algorithms for the management of patients with retinal diseases offer the potential for enhancing visual, anatomical, and quality-of-life outcomes in these patients. Recognition, understanding, and application of these evidence-based advances are imperative to enhance treatment outcomes and patient satisfaction. During Part 1 of th...
|
|
Neuroinflammation in Alzheimer’s Disease: Implications for Early Detection and Treatment
Alzheimer’s disease (AD) is an irreversible, age-related neurodegenerative disorder characterized by a gradual decline in understanding, memory, and ability to perform activities of daily living. With the recent approval of novel AD treatments and the evolving therapeutic landscape, it is imperative for clinicians to stay informed on the current issues surrounding AD. This CE program "Neu...
|
|
Neuroinflammation in Alzheimer’s Disease: Implications for Early Detection and Treatment
Alzheimer’s disease (AD) is an irreversible, age-related neurodegenerative disorder characterized by a gradual decline in understanding, memory, and ability to perform activities of daily living. With the recent approval of novel AD treatments and the evolving therapeutic landscape, it is imperative for clinicians to stay informed on the current issues surrounding AD. This CE program "Neu...
|
|
Nutraceuticals for Dry Eye: Dispelling the Dogma and Embracing the Data
Dry eye disease is a common yet frequently overlooked condition that significantly affects quality of life. Despite an estimated global prevalence of up to 50%, DED is often underdiagnosed and inadequately managed. To limit the burden of DED, it is crucial for clinicians to be adept at recognizing risk factors and making accurate diagnoses. In addition, as treatment options expand to include cli...
|
|
Obesity Forum® FAQs: A Podcast Series
Obesity is an increasingly prevalent, chronic condition associated with substantial risks of morbidity and mortality. It is also a risk factor for some of the leading causes of preventable death, including cardiovascular disease, stroke, type 2 diabetes mellitus, sleep apnea, gallbladder disease, osteoarthritis, and certain types of cancer. The 12th Annual Obesity Forum was a 2-part series that ...
|
|
Patient‐Centered GA Care: A Synergistic Approach to Optimize Management
The recent FDA approval of 2 novel therapies for the management of patients with geographic atrophy (GA) secondary to age-related macular degeneration has further reenforced the necessity for early GA diagnosis to limit progression. Advances in imaging technologies now provide tools for better detection and characterization of GA, along with biomarkers to monitor progression over time. Optometri...
|
|
Pediatric RSV Prevention " Unlocking New Insights
Respiratory syncytial virus (RSV) is a leading cause of bronchiolitis and pneumonia in infants and young children, particularly those under 1 year of age in the United States. While infants born prematurely or with underlying health conditions are at a higher risk for severe RSV illness, the majority of pediatric RSV hospitalizations occur in otherwise healthy infants. Recent advancements in pas...
|
|
Pediatric RSV Prophylaxis: An Evolving Landscape for Prevention " A Wheel of Knowledge Challenge!
Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis and pneumonia in children younger than 1 year of age in the United States. Although certain infants and young children are at higher risk for severe illness due to premature birth or comorbid conditions, the majority of pediatric RSV hospitalizations occur in healthy infants. Emerging passive immunization options, which ...
|
|
Solving the TED Puzzle: Answering Your Questions on Diagnosis to Decision-Making
Thyroid eye disease (TED) is a complex, autoimmune-mediated, inflammatory disorder of the orbit that presents with a range of symptoms, including ocular pain, dysmotility, and changes in ocular structure and function. The disease severely impacts patients' quality of life, often resulting in persistent discomfort, altered appearance, and impaired vision even after the acute phase subsides. ...
|
|
The Retina Radar With Dr. Arshad Khanani on DR, GA, New Mechanisms, and Noninvasive Treatments
Retinal diseases are a leading cause of global vision impairment, driven by an increasing prevalence and the need for more effective treatment. Although clinical trials have shown promising results for various therapies, real-world application often yields less impressive outcomes due to factors like under-treatment and patient non-adherence. New and emerging therapies, particularly for conditio...
|
|
Thyroid Eye Disease Mastery: Multidisciplinary Approaches to Diagnosis and Treatment
Thyroid eye disease (TED) is a multifactorial autoimmune disease with widely varied signs and symptoms. It is believed to result from the stimulation of several receptors located in the orbital fibroblasts and is usually associated with hyperthyroidism. However, 5% of patients with TED have hypothyroidism, and 5% have no sign of thyroid disease; thus, it is frequently misdiagnosed. Misdiagnosis ...
|
|
Thyroid Eye Disease: Unmasking and Taming What’s in Disguise
Thyroid eye disease (TED) is a complex autoimmune-mediated inflammatory disorder of the orbit that is associated with a spectrum of signs and symptoms and varying levels of severity. Early diagnosis and initiation of appropriate treatment are imperative for preventing progression to severe disease and potential vision loss. However, diagnosis can be challenging. Traditional treatments for TED, s...
|